B.S. Chemistry - Centre College (2015)
Prior to enrolling into UKCOM, Louis participated in the NIH Postbac CRTA Program under the guidance of Dr. William Figg (clinical pharmacology/genitourinary malignancies) and Dr. Katherine Warren (pediatric neuro-oncology). During his time at the NIH, Louis conducted pharmacokinetic studies in an effort to develop new therapeutic strategies for the treatment of cancers in children with tumors of the central nervous system. Currently, Louis is continuing his interest in neuro-oncology in the laboratory of Dr. Bjoern Bauer, studying the overexpression of the drug-efflux pumps, P-gp & BCRP, in glioblastoma and other brain tumors.
2018: Professional Student Mentored Research Fellowship (PSMRF) Scholar
Peer CJ, Jung-Min L, Roth J, Rodgers L, Nguyen J, Annunziata CM, Minasian L, Kohn EC, Figg WD. Population pharmacokinetic analyses of the effect of carboplatin pretreatment on olaparib in recurrent or refractory women’s cancers. Cancer Chemother. Pharmacol. 2017 June; 80(1), 165-175. doi: 10.1007/s00280-017-3346-1
Rodgers L, Peer CJ, Figg WD. Diagnosis, staging, and risk stratification in prostate cancer: utilizing diagnostic tools to avoid unnecessary therapies and side effects. Cancer Biol Ther. 2017 May. doi: 10.1080/15384047.2017.1323600
Miyahara H, Yadavilli S, Natsumeda M, Rubens J, Rodgers L, Kambhampati M, Taylor I, Kaur H, Asnaghi L, Eberhart CG, Warren KE, Nazarian J, Raabe EH. The dual mTOR kinase inhibitor TAK 228 inhibits tumorigenicity and enhances radiosensitication in diffuse intrinsic pontine glioma. Cancer Lett. 2017 Apr. doi: 10.1016/j.canlet.2017.04.019
League-Pascual JC, McCully CM, Shandilya S, Ronner L, Rodgers L, Cruz R, Peer CJ, Figg WD, Warren KE. Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model. J. Neurooncol. 2017 Mar; 1-7. doi: 10.1007/s11060-017-2388-x
Peer CJ, Ronner L, Rodgers L, McCully CM, Warren KE, Figg WD. Quantification of temozolomide in nonhuman primate fluids by isocratic ultra-high performance liquid chromatography-tandem mass spectrometry to study brain tissue penetration following intranasal or intravenous delivery. Separations. 2016 Feb; 3(1), 4. doi: 10.3390/chromatography3010004